Anti-c2 antibodies and uses thereof
US-2025376539-A1 · Dec 11, 2025 · US
This page is not indexed by search engines while we improve data quality.
Tsui Ping patents
Tsui Ping is listed as an inventor on 25 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Tsui Ping |
| Total patents | 25 |
| First publication | May 7, 2015 |
| Latest publication | Dec 11, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Humanized anti-c5a antibodies and uses thereof
US-2024376189-A1 · Nov 14, 2024 · US
Humanized anti-C5 antibodies and uses thereof
US-12098190-B2 · Sep 24, 2024 · US
Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties
US-2024124612-A1 · Apr 18, 2024 · US
Humanized anti-c5 antibodies and factor h fusion proteins and uses thereof
US-2024076360-A1 · Mar 7, 2024 · US
Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic properties
US-11767369-B2 · Sep 26, 2023 · US
Nucleic acids encoding anti-VEGF-A antibodies and uses thereof
US-11634483-B2 · Apr 25, 2023 · US
ANTI-avB8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY DISEASE
US-2023112035-A1 · Apr 13, 2023 · US
Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereof
US-11566068-B2 · Jan 31, 2023 · US
Bi-functional humanized anti-c5 antibodies and factor h fusion proteins and uses thereof
US-2022204602-A1 · Jun 30, 2022 · US
Recent patents
Latest publications not already listed above.
Humanized anti-c5 antibodies and uses thereof
US-2022177556-A1 · Jun 9, 2022 · US
Anti-vegf-a antibodies and uses thereof
US-2021147531-A1 · May 20, 2021 · US
Anti-VEGF-A antibodies and uses thereof
US-10919958-B2 · Feb 16, 2021 · US
Anti-vegf-a and anti-ang2 antibodies and uses thereof
US-2021040194-A1 · Feb 11, 2021 · US
Anti-VEGF-A and anti-ANG2 antibodies and uses thereof
US-10836819-B2 · Nov 17, 2020 · US
Alpha-v beta-8 antibodies
US-2020277381-A1 · Sep 3, 2020 · US
Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties
US-2020071423-A1 · Mar 5, 2020 · US
Anti-vegf-a antibodies and uses thereof
US-2019202903-A1 · Jul 4, 2019 · US
Anti-vegf-a and anti-ang2 antibodies and uses thereof
US-2019194308-A1 · Jun 27, 2019 · US
Molecules with Reduced Effector Function and Extended Half-Lives, Compositions, and Uses Thereof
US-2018258178-A1 · Sep 13, 2018 · US
Molecules with reduced effector function and extended half-lives, compositions, and uses thereof
US-10011660-B2 · Jul 3, 2018 · US
Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties
US-2017267780-A1 · Sep 21, 2017 · US
Alpha-v beta-8 antibodies
US-2017129955-A1 · May 11, 2017 · US
Generation of human de novo pIX phage display libraries
US-9062305-B2 · Jun 23, 2015 · US
Molecules with Reduced Effector Function and Extended Half-Lives, Compositions, and Uses Thereof
US-2015125444-A1 · May 7, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Medimmune Ltd | 10 |
| Medimmune Llc | 8 |
| Univ Pennsylvania | 6 |
| Kira Pharmaceuticals Us Llc | 4 |
| Kira Pharmaceuticals Suzhou Ltd | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 19 |
| C07K2317/92 | 17 |
| C07K2317/565 | 13 |
| C07K2317/94 | 13 |
| A61P43/00 | 12 |